Verdence Capital Advisors »

Aziyo Biologics shares owned by Verdence Capital Advisors

Quarter-by-quarter ownership of Aziyo Biologics (ELUT) shares owned by Verdence Capital Advisors from 13F filings

Historical chart of Verdence Capital Advisors investment in Aziyo Biologics

Tip: Access up to 7 years of quarterly data

All positions including Aziyo Biologics held by Verdence Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aziyo Biologics by Verdence Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $45k 14k 3.15
2023-12-31 $31k 14k 2.16
2023-09-30 $21k 14k 1.43
2023-06-30 $34k 14k 2.36

More positions owned by Verdence Capital Advisors

Apple (AAPL)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
JPMorgan Chase & Co. (JPM)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core Us Aggbd Et (AGG)
Broadcom (AVGO)
Amazon (AMZN)
Micron Technology (MU)
Ishares Tr Msci Eafe Etf (EFA)
Visa Com Cl A (V)
Exxon Mobil Corporation (XOM)
Vanguard Scottsdale Fds Vng Rus1000val (VONV)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Costco Wholesale Corporation (COST)

View all positions for Verdence Capital Advisors

Top funds holding Aziyo Biologics

AIGH Capital Management
Nantahala Capital Management
Alyeska Investment Group
Perkins Capital Management
Worth Venture Partners
Vanguard Group
Indie Asset Partners
Millennium Management
Verdence Capital Advisors
Virtu Financial
Us Bancorp
UBS Group
Royal Bank of Canada
Wells Fargo & Company
Jpmorgan Chase & Co

View all funds holding Aziyo Biologics